{"assertion_type":"variation to included disease","version":"3","date_created":"2011-01-25","clinical_assertion_observation_ids":["SCV000028838.0"],"submitter_id":"3","date_last_updated":"2019-08-03","trait_set_id":"2228","review_status":"no assertion criteria provided","variation_archive_id":"VCV000008152","interpretation_description":"protective","submission_id":"3.2014-09-05","submission_names":[],"title":"CX3CR1, VAL249ILE/THR280MET_CORONARY ARTERY DISEASE, RESISTANCE TO","rcv_accession_id":"RCV000008630","internal_id":"28838","variation_id":"8152","clinical_assertion_trait_set_id":"SCV000028838","local_key":"601470.0001_CORONARY ARTERY DISEASE, RESISTANCE TO","record_status":"current","interpretation_date_last_evaluated":"2015-05-18","id":"SCV000028838","interpretation_comments":[]}
{"assertion_type":"variation to included disease","version":"3","date_created":"2012-05-08","clinical_assertion_observation_ids":["SCV000044400.0"],"submitter_id":"3","date_last_updated":"2019-08-03","trait_set_id":"6838","review_status":"no assertion criteria provided","variation_archive_id":"VCV000008152","interpretation_description":"risk factor","submission_id":"3.2014-09-05","submission_names":[],"title":"CX3CR1, VAL249ILE/THR280MET_MACULAR DEGENERATION, AGE-RELATED, 12, SUSCEPTIBILITY TO","rcv_accession_id":"RCV000023109","internal_id":"49656","variation_id":"8152","clinical_assertion_trait_set_id":"SCV000044400","local_key":"601470.0001_MACULAR DEGENERATION, AGE-RELATED, 12, SUSCEPTIBILITY TO","record_status":"current","interpretation_date_last_evaluated":"2013-12-01","id":"SCV000044400","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"3","date_created":"2011-01-25","clinical_assertion_observation_ids":["SCV000028837.0"],"submitter_id":"3","date_last_updated":"2019-08-03","trait_set_id":"2227","review_status":"no assertion criteria provided","variation_archive_id":"VCV000008152","interpretation_description":"Pathogenic","submission_id":"3.2014-09-05","submission_names":[],"title":"CX3CR1, VAL249ILE/THR280MET_HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS","rcv_accession_id":"RCV000008629","internal_id":"28837","variation_id":"8152","clinical_assertion_trait_set_id":"SCV000028837","local_key":"601470.0001_HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS","record_status":"current","interpretation_date_last_evaluated":"2014-09-05","id":"SCV000028837","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"5","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}}]}}","date_created":"2013-03-16","clinical_assertion_observation_ids":["SCV000062127.0"],"submitter_id":"21766","date_last_updated":"2019-08-30","trait_set_id":"3420","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000012610","interpretation_description":"Pathogenic","submission_id":"21766.2019-03-21","submission_names":["SUB5348977"],"rcv_accession_id":"RCV000013444","internal_id":"103327","variation_id":"12610","clinical_assertion_trait_set_id":"SCV000062127","local_key":"26351883|Orphanet:ORPHA3071","record_status":"current","interpretation_date_last_evaluated":"2014-09-23","id":"SCV000062127","interpretation_comments":["{\"text\":\"The Thr58Ile variant in HRAS has been reported in three individuals with clinica l features of Costello syndrome (Gripp 2008, Gripp 2012, LMM unpublished data). It was identified to occur de novo in two of these individuals and segregated w ith disease in one affected relative from one of these families. This variant wa s absent from large population studies. Computational prediction tools and conse rvation analysis suggest that this variant may impact the protein, though this i nformation is not predictive enough to determine pathogenicity. In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partner s.org/LMM).\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","date_created":"2019-02-15","clinical_assertion_observation_ids":["SCV000884146.0"],"submitter_id":"25969","date_last_updated":"2019-07-20","trait_set_id":"9460","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000003520","interpretation_description":"Uncertain significance","submission_id":"25969.2018-10-10","submission_names":["SUB4618058"],"rcv_accession_id":"RCV000153516","internal_id":"1730401","variation_id":"3520","clinical_assertion_trait_set_id":"SCV000884146","local_key":"74380|Not Provided","record_status":"current","interpretation_date_last_evaluated":"2017-05-02","id":"SCV000884146","interpretation_comments":["{\"text\":\"One copy of the c.665C\u003eT; p.Ala222Val variant, also known as C677T or thermolabile variant, was detected in the MTHFR gene by massively parallel sequencing and confirmed by Sanger sequencing. This variant is observed in the general population at an overall allele frequency of 30.8% (85329/277132 alleles, including 15447 homozygotes) in the Genome Aggregation Database. This variant has been studied extensively and is considered a ''susceptibility'' or an ''association'' variant. The thermolabile c.665C\u003eT in a homozygous state has been correlated with reduced enzyme activity and increased homocysteine (Frosst 1995). Recent publication of the American College of Medical Genetics stated that this variant, c.665C\u003eT; p.Ala222Val, in the heterozygous form is unlikely to be of clinical significance (Hickey 2013); however, a possible effect of this variant when paired with the pathogenic MTHFR variant, on the opposite chromosome cannot be excluded. Deep intronic variants and variants in the untranslated region are not analyzed by this method; therefore, another pathogenic MTHFR variant cannot be ruled out.\",\"type\":\"public\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"practice guideline\",\"ID\":[{\"$\":\"25741868\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2015.30\",\"@Source\":\"DOI\"}]}}","date_created":"2019-03-28","clinical_assertion_observation_ids":["SCV000895101.0"],"submitter_id":"500105","date_last_updated":"2019-08-03","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","interpretation_description":"Uncertain significance","submission_id":"500105.2018-11-14","submission_names":["SUB4786732"],"internal_id":"1751540","variation_id":"37594","clinical_assertion_trait_set_id":"SCV000895101","local_key":":Chr.17_41251893_41251893_T_G|OMIM:114480;604370;614320;617883","record_status":"current","interpretation_date_last_evaluated":"2018-10-31","id":"SCV000895101","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}}}","date_created":"2016-03-15","clinical_assertion_observation_ids":["SCV000265873.0"],"submitter_id":"505720","date_last_updated":"2019-08-03","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","interpretation_description":"Uncertain significance","submission_id":"505720.2016-02-27","submission_names":["Chinese507BC_BRCA"],"internal_id":"498108","variation_id":"37594","clinical_assertion_trait_set_id":"SCV000265873","local_key":"NM_007294.3:c.446A\u003eC|MedGen:CN221572","record_status":"current","interpretation_date_last_evaluated":"2015-11-01","id":"SCV000265873","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2019-05-17","clinical_assertion_observation_ids":["SCV000910906.0"],"submitter_id":"505849","date_last_updated":"2019-08-03","trait_set_id":"13598","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","interpretation_description":"Likely benign","submission_id":"505849.2018-11-06","submission_names":["SUB4721021"],"rcv_accession_id":"RCV000219296","internal_id":"1778861","variation_id":"37594","clinical_assertion_trait_set_id":"SCV000910906","local_key":"Db4KrQBSZeoE7-orUyypkaRSy9Lm52xvIWbvYpjplzM|MedGen:C0027672","record_status":"current","interpretation_date_last_evaluated":"2016-04-19","id":"SCV000910906","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (10/2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/aH4uL7vL/mid-7377_ambry_classification_scheme_oct_2015.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","date_created":"2016-05-27","clinical_assertion_observation_ids":["SCV000274232.0"],"submitter_id":"61756","date_last_updated":"2019-08-03","trait_set_id":"13598","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","interpretation_description":"Uncertain significance","submission_id":"61756.2016-05-09","submission_names":[],"rcv_accession_id":"RCV000219296","internal_id":"510686","variation_id":"37594","clinical_assertion_trait_set_id":"SCV000274232","local_key":"a31329","record_status":"current","interpretation_date_last_evaluated":"2016-02-19","id":"SCV000274232","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"3","date_created":"2012-11-07","clinical_assertion_observation_ids":["SCV000053775.0"],"submitter_id":"500037","date_last_updated":"2019-08-03","trait_set_id":"1917","review_status":"no assertion criteria provided","variation_archive_id":"VCV000037594","interpretation_description":"Uncertain significance","submission_id":"500037.2012-07-24","submission_names":[],"title":"NM_007294.3:c.446A\u003eC AND Breast-ovarian cancer, familial 1","rcv_accession_id":"RCV000031175","internal_id":"89390","variation_id":"37594","clinical_assertion_trait_set_id":"SCV000053775","local_key":"SCRP_var_219","record_status":"current","interpretation_date_last_evaluated":"2008-09-04","id":"SCV000053775","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"5","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2017-04-24","clinical_assertion_observation_ids":["SCV000570422.0"],"submitter_id":"26957","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","interpretation_description":"Uncertain significance","submission_id":"26957.2019-01-29","submission_names":["SUB5098196"],"rcv_accession_id":"RCV000479398","internal_id":"1105529","variation_id":"37594","clinical_assertion_trait_set_id":"SCV000570422","local_key":"GDX:1080047|Not Provided","record_status":"current","interpretation_date_last_evaluated":"2018-09-25","id":"SCV000570422","interpretation_comments":["{\"text\":\"This variant is denoted BRCA1 c.446A\u003eC at the cDNA level, p.Glu149Ala (E149A) at the protein level, and results in the change of a Glutamic Acid to an Alanine (GAA\u003eGCA). Using alternate nomenclature, this variant would be defined as BRCA1 565A\u003eC. This variant was observed in several individuals with breast cancer and in one individual with gastric cancer (Zhang 2012, Lu 2015, Zhong 2016, Wei 2018). Functional analysis of this variant showed no significant difference as compared to wild type in a homologous directed repair assay (Lu 2015). BRCA1 Glu149Ala was observed at an allele frequency of 0.06% (12/18870) in individuals of East Asian ancestry in large population cohorts (Lek 2016). This variant is located within a region that binds BRD7 (Harte 2010). Protein-based in silico analysis, which includes protein predictors and evolutionary conservation, predicts that this variant is probably damaging to protein structure and function, and splicing models are uninformative in their assessment as to whether or not the variant is damaging. Based on currently available evidence, it is unclear whether BRCA1 Glu149Ala is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.\"}"]}
{"assertion_type":"variation to disease","version":"5","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26689913\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22116506\",\"@Source\":\"PubMed\"}}]}}","date_created":"2017-04-13","clinical_assertion_observation_ids":["SCV000549301.0"],"submitter_id":"500031","date_last_updated":"2019-08-15","trait_set_id":"7920","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","interpretation_description":"Uncertain significance","submission_id":"500031.2019-03-28","submission_names":["SUB5371970"],"rcv_accession_id":"RCV000458634","internal_id":"1062197","variation_id":"37594","clinical_assertion_trait_set_id":"SCV000549301","local_key":"676082|MedGen:C0677776","record_status":"current","interpretation_date_last_evaluated":"2018-12-19","id":"SCV000549301","interpretation_comments":["{\"text\":\"This sequence change replaces glutamic acid with alanine at codon 149 of the BRCA1 protein (p.Glu149Ala). The glutamic acid residue is moderately conserved and there is a moderate physicochemical difference between glutamic acid and alanine. This variant is present in population databases (rs397507233, ExAC 0.07%). This variant has been reported in individuals affected with breast cancer (PMID: 22116506, 27257965) and stomach cancer (PMID: 26689913). ClinVar contains an entry for this variant (Variation ID: 37594). Experimental studies have shown that this missense change does not impact BRCA1 homology-directed repair activity (PMID: 26689913). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.\"}"]}
{"assertion_type":"variation to disease","version":"6","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","date_created":"2013-03-16","clinical_assertion_observation_ids":["SCV000063451.0"],"submitter_id":"21766","date_last_updated":"2019-08-27","trait_set_id":"9590","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000046503","interpretation_description":"Likely benign","submission_id":"21766.2019-03-21","submission_names":["SUB5348979"],"rcv_accession_id":"RCV000039762","internal_id":"104651","variation_id":"46503","clinical_assertion_trait_set_id":"SCV000063451","local_key":"30968208|not specified","record_status":"current","interpretation_date_last_evaluated":"2017-09-04","id":"SCV000063451","interpretation_comments":["{\"text\":\"p.Ala1855Ala in exon 33 of PCDH15: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located ne ar a splice junction and has been identified in 0.3% (381/126618) European chro mosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute .org; dbSNP rs111033445).\"}"]}
{"assertion_type":"variation to disease","version":"6","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27068579\",\"@Source\":\"PubMed\"}}}}","date_created":"2013-03-16","clinical_assertion_observation_ids":["SCV000065162.0"],"submitter_id":"21766","date_last_updated":"2019-08-27","trait_set_id":"9590","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000048176","interpretation_description":"Uncertain significance","submission_id":"21766.2019-03-21","submission_names":["SUB5348979"],"rcv_accession_id":"RCV000041467","internal_id":"106362","variation_id":"48176","clinical_assertion_trait_set_id":"SCV000065162","local_key":"11832988|not specified","record_status":"current","interpretation_date_last_evaluated":"2018-08-21","id":"SCV000065162","interpretation_comments":["{\"text\":\"The p.Arg544Cys variant in OTOF has been identified in 1 individual with autosom al recessive sensorineural hearing loss who carried a second OTOF variant of unc ertain significance; it is unclear whether these variants are in trans (Sommen 2 016). The p.Arg544Cys variant has also been identified by our laboratory in 6 in dividuals with hearing loss; however, none of these individuals carried a varian t affecting the other copy of the OTOF gene or was reported to have auditory neu ropathy typically associated with OTOF related hearing loss. This variant has be en reported in ClinVar (Variation ID: 48176). It has been identified in 0.15% (1 93/125430) of European chromosomes by the Genome Aggregation Database (gnomAD, h ttp://gnomad.broadinstitute.org); however, this frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation anal ysis suggest that the p.Arg544Cys variant may impact the protein, though this in formation is not predictive enough to determine pathogenicity. In summary, the c linical significance of the p.Arg544Cys variant is uncertain. ACMG/AMP Criteria applied: PP3, BS1_Supporting.\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"30718709\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"30718709\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"30718709\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"Investigation of 124 genes associated with retinal dystrophies\"},\"StudyName\":{\"$\":\"VeluxRD\"}}","date_created":"2019-07-19","clinical_assertion_observation_ids":["SCV000926774.0"],"submitter_id":"1147","date_last_updated":"2019-08-03","trait_set_id":"6496","review_status":"no assertion criteria provided","variation_archive_id":"VCV000007884","interpretation_description":"Pathogenic","submission_id":"1147.2018-12-05","submission_names":["SUB4878664"],"rcv_accession_id":"RCV000787769","internal_id":"1812551","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000926774","local_key":"NM_000350.2:c.6148G\u003eC|MedGen:C0035334","record_status":"current","interpretation_date_last_evaluated":"2018-04-01","id":"SCV000926774","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","content":"{\"Comment\":{\"$\":\"http://phencode.bx.psu.edu/cgi-bin/phencode/phencode?build=hg19\u0026id=RISN_ABCR:c.6148G\u003eC\"}}","date_created":"2014-02-18","clinical_assertion_observation_ids":["SCV000117933.0"],"submitter_id":"500304","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"no assertion provided","variation_archive_id":"VCV000007884","interpretation_description":"not provided","submission_id":"500304.2012-12-20","submission_names":["RISN_LSDB_112012"],"rcv_accession_id":"RCV000078671","internal_id":"205773","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000117933","local_key":"RISN-ABCR:c.6148G\u003eC","record_status":"current","id":"SCV000117933","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification Criteria 09 May 2019\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/d4q7wshq/icsl_variant_classification_criteria_09_may_2019.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23940504\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26593885\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973280\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28224992\",\"@Source\":\"PubMed\"}}]}}","date_created":"2019-05-23","clinical_assertion_observation_ids":["SCV000914269.0"],"submitter_id":"504895","date_last_updated":"2019-08-03","trait_set_id":"33431","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Uncertain significance","submission_id":"504895.2019-04-05","submission_names":["SUB5424092"],"rcv_accession_id":"RCV000778139","internal_id":"1789326","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000914269","local_key":"909158","record_status":"current","interpretation_date_last_evaluated":"2019-04-05","id":"SCV000914269","interpretation_comments":["{\"text\":\"Across a selection of available literature, the ABCA4 c.6148G\u003eC (p.Val2050Leu) missense variant has been reported in at least seven individuals affected with Stargardt macular degeneration including in three in a compound heterozygous state, in one in a heterozygous state and in at least three with unknown zygosity. The variant has also been reported in two brothers affected with cone-rod dystrophy in a compound heterozygous state with a frameshift variant on the second allele, and in a heterozygous state in one individual affected with macular dystrophy (Allikmets et al. 1997; Lewis et al. 1999; Corton et al. 2013; Schulz et al. 2017; Haer-Wigman et al. 2017). The variant failed to segregate with the disorder in one family affected with autosomal recessive retinitis pigmentosa and in one with autosomal dominant macular dystrophy (Wiszniewski et al. 2005; Poloschek et al. 2010). The p.Val2050Leu variant has also been found as a complex allele in cis with either a stop-gained variant or a missense variant in individuals affected with ABCA4-related disorders (Sciezynska et al. 2016; Schulz et al. 2017). The variant was found in a heterozygous state in one of 1528 control individuals and in one unaffected parent (Allikmets et al. 1997; Lewis et al. 1999; Corton et al. 2013; Sciezynska et al. 2016). This variant is reported at a frequency of 0.028846 in Puerto Ricans from Puerto Rico from the 1000 Genomes Project and in one homozygote in the European (non-Finnish) population of the Genome Aggregation Database. Poloschek et al. (2010) showed that, upon ophthalmic examination, heterozygous carriers of the p.Val2050Leu variant display centrally reduced mfERG amplitudes and additional minor fundus abnormalities, suggesting that the p.Val2050Leu variant is capable of mildly reducing macular function in the heterozygous state without an additional pathogenic variant on the second allele. Based on the collective evidence the p.Val2050Leu variant is classified as a variant of unknown significance but suspicious for pathogenicity for ABCA4-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28041643\",\"@Source\":\"PubMed\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-09-07","clinical_assertion_observation_ids":["SCV000599010.0"],"submitter_id":"505998","date_last_updated":"2019-08-03","trait_set_id":"33742","review_status":"no assertion criteria provided","variation_archive_id":"VCV000007884","interpretation_description":"Likely pathogenic","submission_id":"505998.2017-08-18","submission_names":["NIHR_Bioresource_Rare_Diseases_Retinal_Dystrophy"],"rcv_accession_id":"RCV000504806","internal_id":"1160860","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000599010","local_key":"c.6148G\u003eC_HP:0000548","record_status":"current","interpretation_date_last_evaluated":"2015-01-01","id":"SCV000599010","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","date_created":"2016-12-02","clinical_assertion_observation_ids":["SCV000359223.0"],"submitter_id":"504895","date_last_updated":"2019-08-03","trait_set_id":"33382","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Likely benign","submission_id":"504895.2016-10-18","submission_names":["ICSL_2016Q4"],"rcv_accession_id":"RCV000393715","internal_id":"672745","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000359223","local_key":"293398|Retinitis Pigmentosa, Recessive","record_status":"current","interpretation_date_last_evaluated":"2016-06-14","id":"SCV000359223","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","date_created":"2016-12-02","clinical_assertion_observation_ids":["SCV000359224.0"],"submitter_id":"504895","date_last_updated":"2019-08-03","trait_set_id":"33383","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Likely benign","submission_id":"504895.2016-10-18","submission_names":["ICSL_2016Q4"],"rcv_accession_id":"RCV000285333","internal_id":"672746","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000359224","local_key":"293398|Cone-Rod Dystrophy, Recessive","record_status":"current","interpretation_date_last_evaluated":"2016-06-14","id":"SCV000359224","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","date_created":"2016-12-02","clinical_assertion_observation_ids":["SCV000359225.0"],"submitter_id":"504895","date_last_updated":"2019-08-03","trait_set_id":"33430","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Likely benign","submission_id":"504895.2016-10-18","submission_names":["ICSL_2016Q4"],"rcv_accession_id":"RCV000340261","internal_id":"672747","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000359225","local_key":"293398|Stargardt Disease, Recessive","record_status":"current","interpretation_date_last_evaluated":"2016-06-14","id":"SCV000359225","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","date_created":"2016-12-02","clinical_assertion_observation_ids":["SCV000359226.0"],"submitter_id":"504895","date_last_updated":"2019-08-03","trait_set_id":"33398","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Likely benign","submission_id":"504895.2016-10-18","submission_names":["ICSL_2016Q4"],"rcv_accession_id":"RCV000393726","internal_id":"672748","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000359226","local_key":"293398|Macular Degeneration","record_status":"current","interpretation_date_last_evaluated":"2016-06-14","id":"SCV000359226","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Schulz et al. (Invest Ophthalmol Vis Sci. 2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}],\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23940504\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"28118664\",\"@Source\":\"PubMed\"}}]}}","date_created":"2016-06-16","clinical_assertion_observation_ids":["SCV000281950.0"],"submitter_id":"505832","date_last_updated":"2019-08-03","trait_set_id":"1448","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Likely pathogenic","submission_id":"505832.2016-05-25","submission_names":["STGD2016"],"rcv_accession_id":"RCV000008335","internal_id":"533093","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000281950","local_key":"162","record_status":"current","interpretation_date_last_evaluated":"2016-01-01","id":"SCV000281950","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"3","date_created":"2011-01-25","clinical_assertion_observation_ids":["SCV000028543.0"],"submitter_id":"3","date_last_updated":"2019-08-03","trait_set_id":"1448","review_status":"no assertion criteria provided","variation_archive_id":"VCV000007884","interpretation_description":"Pathogenic","submission_id":"3.2010-12-30","submission_names":[],"title":"ABCA4, VAL2050LEU_STARGARDT DISEASE 1","rcv_accession_id":"RCV000008335","internal_id":"28543","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000028543","local_key":"601691.0005_STARGARDT DISEASE 1","record_status":"current","interpretation_date_last_evaluated":"2016-12-29","id":"SCV000028543","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"3","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2017-03-03","clinical_assertion_observation_ids":["SCV000511911.0"],"submitter_id":"26957","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Uncertain significance","submission_id":"26957.2019-01-29","submission_names":["SUB5098196"],"rcv_accession_id":"RCV000078671","internal_id":"977225","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000511911","local_key":"GDX:874|Not Provided","record_status":"current","interpretation_date_last_evaluated":"2018-11-07","id":"SCV000511911","interpretation_comments":["{\"text\":\"The V2050L variant in the ABCA4 gene has been reported previously in association with Stargardt disease, macular dystrophy, cone-rod dystrophy, and age-related macular degeneration (Lewis et al., 1999; Wiszniewski et al., 2005; Poloschek et al., 2010; Fritsche et al., 2012; Corton et al., 2013). Poloschek et al. (2010) reported that V2050L heterozygous carriers show centrally reduced mfERG amplitudes and additional minor fundus abnormalities, which suggested that the V2050L variant in the heterozygous state is capable of mildly reducing macular function without an additional pathogenic variant on the second allele. However, the V2050L variant is observed in 202/34420 (0.5869%) alleles from individuals of Latino background and 787/277174 (0.2839%) global alleles, with one homozygote reported (Lek et al., 2016). The V2050L variant is a conservative amino acid substitution, which occurs at a position that is conserved across species. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. We interpret V2050L as a variant of uncertain significance.\"}"]}
{"assertion_type":"variation to disease","version":"8","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=ABCA4\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"16103129\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20335603\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9054934\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"http://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/?chr=1\u0026from=94467548\u0026to=94467548\"}}]}}","date_created":"2014-01-16","clinical_assertion_observation_ids":["SCV000110530.0"],"submitter_id":"500060","date_last_updated":"2019-08-03","trait_set_id":"9590","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000007884","interpretation_description":"Benign","submission_id":"500060.2018-09-19","submission_names":["SUB4534263"],"rcv_accession_id":"RCV000259072","internal_id":"192622","variation_id":"7884","clinical_assertion_trait_set_id":"SCV000110530","local_key":"11450_000000","record_status":"current","interpretation_date_last_evaluated":"2016-11-17","id":"SCV000110530","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"4","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"14688025\",\"@Source\":\"PubMed\"}}}}","date_created":"2013-03-16","clinical_assertion_observation_ids":["SCV000061597.0"],"submitter_id":"21766","date_last_updated":"2019-08-30","trait_set_id":"4069","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000013972","interpretation_description":"Pathogenic","submission_id":"21766.2019-03-21","submission_names":["SUB5348977"],"rcv_accession_id":"RCV000037932","internal_id":"102797","variation_id":"13972","clinical_assertion_trait_set_id":"SCV000061597","local_key":"15072993|MeSH:D002289","record_status":"current","interpretation_date_last_evaluated":"2012-06-11","id":"SCV000061597","interpretation_comments":["{\"text\":\"This variant has been reported as a somatic change in large intestine, skin, end ometrium, stomach, and ovary (COSMIC, Fransen 2004) and has been observed in up to 11% of BRAF mutant positive lung adenocarcinoma (Paik 2011).\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh38","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-09-20","clinical_assertion_observation_ids":["SCV000807826.0"],"submitter_id":"1024","date_last_updated":"2019-08-03","trait_set_id":"35108","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Uncertain significance","submission_id":"1024.2018-07-17","submission_names":["SUB4304907"],"rcv_accession_id":"RCV000680453","internal_id":"1575248","variation_id":"822","clinical_assertion_trait_set_id":"SCV000807826","local_key":"APC-B1|MedGen:CN240755","record_status":"current","interpretation_date_last_evaluated":"2018-06-01","id":"SCV000807826","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},\"StudyName\":{\"$\":\"ClinSeq\"}}","date_created":"2013-03-26","clinical_assertion_observation_ids":["SCV000043125.0"],"submitter_id":"1160","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","interpretation_description":"variant of unknown significance","submission_id":"1160.2012-07-15","submission_names":["ClinSeq_cancer"],"rcv_accession_id":"RCV000034388","internal_id":"98286","variation_id":"822","clinical_assertion_trait_set_id":"SCV000043125","local_key":"NM_000038.4:c.3920T\u003eA|not provided","record_status":"current","interpretation_date_last_evaluated":"2012-07-13","id":"SCV000043125","interpretation_comments":["{\"text\":\"Converted during submission to Uncertain significance.\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-09-12","clinical_assertion_observation_ids":["SCV000805404.0"],"submitter_id":"239772","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Uncertain significance","submission_id":"239772.2018-01-29","submission_names":["SUB3589995"],"rcv_accession_id":"RCV000034388","internal_id":"1570355","variation_id":"822","clinical_assertion_trait_set_id":"SCV000805404","local_key":"NM_000038.5:c.3920T\u003eA|not provided","record_status":"current","interpretation_date_last_evaluated":"2016-01-06","id":"SCV000805404","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_%25282015%2529_v1.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24310308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17854661\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15712637\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11001924\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-01-04","clinical_assertion_observation_ids":["SCV000677724.0"],"submitter_id":"320494","date_last_updated":"2019-08-03","trait_set_id":"6265","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Likely pathogenic","submission_id":"320494.2017-06-22","submission_names":["SUB2805501"],"rcv_accession_id":"RCV000020088","internal_id":"1328882","variation_id":"822","clinical_assertion_trait_set_id":"SCV000677724","local_key":"76464|OMIM:175100","record_status":"current","interpretation_date_last_evaluated":"2016-09-27","id":"SCV000677724","interpretation_comments":["{\"text\":\"I1307K is associated with a 10-20% lifetime risk of developing colon cancer in individuals of Ashkenazi Jewish ancestry and is not known to cause classic or attenuated FAP.\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"LabCorp Variant Classification Summary - May 2015.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26394139\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26300997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-03-15","clinical_assertion_observation_ids":["SCV000694042.0"],"submitter_id":"500026","date_last_updated":"2019-08-03","trait_set_id":"215","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Uncertain significance","submission_id":"500026.2018-01-25","submission_names":["2016-2017-variants"],"rcv_accession_id":"RCV000000864","internal_id":"1360394","variation_id":"822","clinical_assertion_trait_set_id":"SCV000694042","local_key":"NM_000038.5:c.3920T\u003eA|MedGen:CN221809","record_status":"current","interpretation_date_last_evaluated":"2016-12-02","id":"SCV000694042","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","date_created":"2011-05-06","clinical_assertion_observation_ids":["SCV000040392.0"],"submitter_id":"500062","date_last_updated":"2019-08-03","trait_set_id":"6265","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","interpretation_description":"pathologic","submission_id":"500062.2013-01-08","submission_names":[],"title":"NM_000038.3:c.3920T\u003eA and APC-Associated Polyposis Conditions","rcv_accession_id":"RCV000020088","internal_id":"40392","variation_id":"822","clinical_assertion_trait_set_id":"SCV000040392","local_key":"NM_000038.3:c.3920T\u003eA_NBK1345","record_status":"current","interpretation_date_last_evaluated":"2011-10-27","id":"SCV000040392","interpretation_comments":["{\"text\":\"Converted during submission to Pathogenic.\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest pathogenicity assessment criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16875934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12533824\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135136\",\"@Source\":\"PubMed\"}}]}}","date_created":"2017-09-27","clinical_assertion_observation_ids":["SCV000600091.0"],"submitter_id":"500110","date_last_updated":"2019-08-03","trait_set_id":"9590","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Uncertain significance","submission_id":"500110.2017-08-01","submission_names":["SUB2915479"],"rcv_accession_id":"RCV000120049","internal_id":"1163765","variation_id":"822","clinical_assertion_trait_set_id":"SCV000600091","local_key":"NM_000038.5:c.3920T\u003eA|not provided","record_status":"current","interpretation_date_last_evaluated":"2017-02-08","id":"SCV000600091","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-10-11","clinical_assertion_observation_ids":["SCV000839876.0"],"submitter_id":"500199","date_last_updated":"2019-08-03","trait_set_id":"6265","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"risk factor","submission_id":"500199.2018-06-14","submission_names":["SUB4151980"],"rcv_accession_id":"RCV000020088","internal_id":"1637429","variation_id":"822","clinical_assertion_trait_set_id":"SCV000839876","local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","record_status":"current","interpretation_date_last_evaluated":"2017-06-02","id":"SCV000839876","interpretation_comments":["{\"text\":\"The c.3920T\u003eA (p.Ile1307Lys) variant in the APC gene has been reported as a common risk allele associated with familial colorectal cancer in the Ashkenazi Jewish population [PMID 18770064, 24416237]. The c.3920T\u003eA variant has been reported to result in an adenine replacing a thymine and creating an oligo-adenine (A8) tract that appears to be inherently prone to further somatic mis-pairing and slippage during DNA replication, thereby creating a frameshift change [PMID 9288102, 18770064 and 244162370]. However, this variant has also been reported at a high frequency, present in 6% of Ashkenazi Jews and about 28% of Ashkenazim with a family history of colorectal cancer [PMID: 9288102]. Isoleucine at amino acid position 1307 of the APC protein is weakly conserved during evolution. While not validated for clinical use, the SIFT and PolyPhen-2 algorithms predict this variant to be benign. Ashkenazi Jews who carry the p.Ile1307Lys variant are at increased risk for colorectal neoplasia: the risk for colorectal neoplasia in heterozygous Ashkenazi Jewish individuals was estimated to be between 1.7 to 2.17 compared to non carrier individuals [PMID 12173321, 23576677, 23896379]. This variant is classified as as a risk allele with an increased risk for colorectal neoplasia in the Ashkenazi Jewish population. However the risk in non Jewish populations has not been determined.\"}"]}
{"assertion_type":"variation to disease","version":"1","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},\"Comment\":{\"$\":\"Please see associated publication for description of ethnicities\"}}","date_created":"2014-06-09","clinical_assertion_observation_ids":["SCV000084184.0","SCV000084184.1","SCV000084184.2","SCV000084184.3","SCV000084184.4","SCV000084184.5","SCV000084184.6"],"submitter_id":"504914","date_last_updated":"2019-08-03","trait_set_id":"9590","review_status":"no assertion provided","variation_archive_id":"VCV000000822","interpretation_description":"not provided","submission_id":"504914.2014-05-29","submission_names":["Cancer_genes_01"],"rcv_accession_id":"RCV000120049","internal_id":"281153","variation_id":"822","clinical_assertion_trait_set_id":"SCV000084184","local_key":"MedGen:CN169374","record_status":"current","interpretation_date_last_evaluated":"2013-09-19","id":"SCV000084184","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-10-05","clinical_assertion_observation_ids":["SCV000821694.0"],"submitter_id":"505504","date_last_updated":"2019-08-03","trait_set_id":"13598","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"risk factor","submission_id":"505504.2018-08-08","submission_names":["SUB4381212"],"rcv_accession_id":"RCV000115087","internal_id":"1609757","variation_id":"822","clinical_assertion_trait_set_id":"SCV000821694","local_key":"NM_000038.5:c.3920T\u003eA|MedGen:C0027672","record_status":"current","interpretation_date_last_evaluated":"2018-08-01","id":"SCV000821694","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-11-02","clinical_assertion_observation_ids":["SCV000610138.0"],"submitter_id":"505698","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Uncertain significance","submission_id":"505698.2017-10-05","submission_names":[],"rcv_accession_id":"RCV000034388","internal_id":"1190191","variation_id":"822","clinical_assertion_trait_set_id":"SCV000610138","local_key":"19388615","record_status":"current","interpretation_date_last_evaluated":"2017-07-27","id":"SCV000610138","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2019-02-15","clinical_assertion_observation_ids":["SCV000883121.0"],"submitter_id":"506039","date_last_updated":"2019-08-26","trait_set_id":"6265","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Uncertain significance","submission_id":"506039.2018-11-26","submission_names":["SUB4842992"],"rcv_accession_id":"RCV000020088","internal_id":"1729239","variation_id":"822","clinical_assertion_trait_set_id":"SCV000883121","local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","record_status":"current","interpretation_date_last_evaluated":"2018-11-21","id":"SCV000883121","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16140997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19047896\",\"@Source\":\"PubMed\"}}]},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2017-08-25","clinical_assertion_observation_ids":["SCV000591159.0"],"submitter_id":"506152","date_last_updated":"2019-08-03","trait_set_id":"9590","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Uncertain significance","submission_id":"506152.2017-04-19","submission_names":["SHS20170111"],"rcv_accession_id":"RCV000120049","internal_id":"1147603","variation_id":"822","clinical_assertion_trait_set_id":"SCV000591159","local_key":"NM_000038.5:c.3920T\u003eA|not specified","record_status":"current","interpretation_date_last_evaluated":"2016-08-15","id":"SCV000591159","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-11-21","clinical_assertion_observation_ids":["SCV000853088.0"],"submitter_id":"506211","date_last_updated":"2019-08-03","trait_set_id":"1735","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"risk factor","submission_id":"506211.2018-10-29","submission_names":["SUB4705375"],"rcv_accession_id":"RCV000722046","internal_id":"1663716","variation_id":"822","clinical_assertion_trait_set_id":"SCV000853088","local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0699790","record_status":"current","interpretation_date_last_evaluated":"2017-01-01","id":"SCV000853088","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","date_created":"2018-03-01","clinical_assertion_observation_ids":["SCV000693480.0"],"submitter_id":"506273","date_last_updated":"2019-08-03","trait_set_id":"13598","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","interpretation_description":"risk factor","submission_id":"506273.2017-11-15","submission_names":["SUB3222006"],"rcv_accession_id":"RCV000115087","internal_id":"1359177","variation_id":"822","clinical_assertion_trait_set_id":"SCV000693480","local_key":"CCDS4107.1:c.3920T\u003eA|Hereditary cancer-predisposing syndrome","record_status":"current","interpretation_date_last_evaluated":"2017-11-10","id":"SCV000693480","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Shirts et al. (Genet Med 2016)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","date_created":"2016-03-19","clinical_assertion_observation_ids":["SCV000266006.0","SCV000266006.1","SCV000266006.2","SCV000266006.3","SCV000266006.4","SCV000266006.5","SCV000266006.6","SCV000266006.7","SCV000266006.8"],"submitter_id":"506834","date_last_updated":"2019-08-03","trait_set_id":"1570","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"risk factor","submission_id":"506834.2016-03-03","submission_names":["GIM_BROCA"],"rcv_accession_id":"RCV000210085","internal_id":"498299","variation_id":"822","clinical_assertion_trait_set_id":"SCV000266006","local_key":"c.3920T\u003eA","record_status":"current","interpretation_date_last_evaluated":"2015-11-20","id":"SCV000266006","interpretation_comments":["{\"text\":\"Low penetrance mutation that is associated with a small increase in risk of colon cancer and with an increased risk of colon polyps (Boursi 2013)\"}"]}
{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","date_created":"2017-09-27","clinical_assertion_observation_ids":["SCV000602533.0"],"submitter_id":"25969","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Likely benign","submission_id":"25969.2018-10-10","submission_names":["SUB4618058"],"rcv_accession_id":"RCV000034388","internal_id":"1166229","variation_id":"822","clinical_assertion_trait_set_id":"SCV000602533","local_key":"11931|Not Provided","record_status":"current","interpretation_date_last_evaluated":"2018-06-20","id":"SCV000602533","interpretation_comments":["{\"text\":\"The APC c.3920T\u003eA; p.Ile1307Lys variant has been reported extensively in the literature. One recent meta-analysis of 30 published population studies, all of which examined the association between p.Ile1307Lys and colorectal neoplasia, colorectal adenoma, and/or colorectal cancer, concluded that this variant confers a two-fold increased risk of developing a colorectal neoplasia to persons of Ashkenazi Jewish ancestry (Liang 2013 and references therein). However, the c.3920T\u003eA;p.Ile1307Lys variant is observed in the general population at an overall frequency of 0.18% (506/276756 alleles, 6 homozygotes) in the Genome Aggregation Database. Due to the high frequency in the general population, this variant is considered likely benign. REFERENCES Liang et al. APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis. Am J Epidemiol. 2013;177(11):1169-1179.\"}"]}
{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"DGD Variant Analysis Guidelines\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"DGD_Variant_Analysis_Guidelines.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx\"}}},\"StudyDescription\":{\"$\":\"Clinical exome data\"}}","date_created":"2016-07-29","clinical_assertion_observation_ids":["SCV000297021.0"],"submitter_id":"165021","date_last_updated":"2019-08-03","trait_set_id":"8942","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Uncertain significance","submission_id":"165021.2016-01-06","submission_names":["exome2015-12-22"],"rcv_accession_id":"RCV000238802","internal_id":"574598","variation_id":"822","clinical_assertion_trait_set_id":"SCV000297021","local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0032580","record_status":"current","interpretation_date_last_evaluated":"2015-11-24","id":"SCV000297021","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","date_created":"2018-10-05","clinical_assertion_observation_ids":["SCV000838110.0"],"submitter_id":"500035","date_last_updated":"2019-08-03","trait_set_id":"6265","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Likely pathogenic","submission_id":"500035.2018-11-11","submission_names":["MENDELICS_CLINVAR_015"],"rcv_accession_id":"RCV000020088","internal_id":"1610680","variation_id":"822","clinical_assertion_trait_set_id":"SCV000838110","local_key":"NC_000005.9:g.112175211T\u003eA|MedGen:C2713442","record_status":"current","interpretation_date_last_evaluated":"2018-07-02","id":"SCV000838110","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-02-16","clinical_assertion_observation_ids":["SCV000686956.0"],"submitter_id":"505849","date_last_updated":"2019-08-03","trait_set_id":"13598","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Likely pathogenic","submission_id":"505849.2018-11-06","submission_names":["SUB4721021"],"rcv_accession_id":"RCV000115087","internal_id":"1344252","variation_id":"822","clinical_assertion_trait_set_id":"SCV000686956","local_key":"Db4KrQBSZeoE7-orUyypkal4dklV7Tc_lQTp9W4PGUo|MedGen:C0027672","record_status":"current","interpretation_date_last_evaluated":"2018-05-21","id":"SCV000686956","interpretation_comments":[]}
{"assertion_type":"variation to included disease","version":"3","date_created":"2011-01-25","clinical_assertion_observation_ids":["SCV000021015.0"],"submitter_id":"3","date_last_updated":"2019-08-03","trait_set_id":"216","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","interpretation_description":"risk factor","submission_id":"3.2010-12-30","submission_names":[],"title":"APC, ILE1307LYS_BREAST CANCER, SUSCEPTIBILITY TO","rcv_accession_id":"RCV000000865","internal_id":"21015","variation_id":"822","clinical_assertion_trait_set_id":"SCV000021015","local_key":"611731.0029_BREAST CANCER, SUSCEPTIBILITY TO","record_status":"current","interpretation_date_last_evaluated":"2003-12-01","id":"SCV000021015","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"3","date_created":"2011-01-25","clinical_assertion_observation_ids":["SCV000021014.0"],"submitter_id":"3","date_last_updated":"2019-08-03","trait_set_id":"215","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","interpretation_description":"risk factor","submission_id":"3.2014-02-19","submission_names":[],"title":"APC, ILE1307LYS_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","rcv_accession_id":"RCV000000864","internal_id":"21014","variation_id":"822","clinical_assertion_trait_set_id":"SCV000021014","local_key":"611731.0029_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","record_status":"current","interpretation_date_last_evaluated":"2019-04-01","id":"SCV000021014","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"4","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification(06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2014-05-13","clinical_assertion_observation_ids":["SCV000148996.0"],"submitter_id":"26957","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"risk factor","submission_id":"26957.2018-09-07","submission_names":["SUB4498316"],"rcv_accession_id":"RCV000034388","internal_id":"269650","variation_id":"822","clinical_assertion_trait_set_id":"SCV000148996","local_key":"GDX:3786|Not Provided","record_status":"current","interpretation_date_last_evaluated":"2015-05-08","id":"SCV000148996","interpretation_comments":["{\"text\":\"This variant is denoted APC c.3920T\u003eA at the DNA level and p.Ile1307Lys (I1307K) at the protein level, replacing an Isoleucine with a Lysine. APC Ile1307Lys is a common variant, observed at an allele frequency of 3.7% (371/10,138) in individuals of Ashkenazi Jewish ancestry in large population cohorts (Lek 2016) and in up to 11% of individuals in Ashkenazi Jewish cohorts in the literature (Liang 2013, Boursi 2013). A meta-analysis of epidemiologic studies of APC polymorphisms suggests that individuals of Ashkenazi Jewish ancestry who carry this variant have a 2-fold increased risk of colorectal cancer (Liang 2013). However, studies of this variant in other populations did not report an increased risk of colorectal cancer (Liang 2013); therefore, the clinical significance in individuals without Jewish ancestry is not clear at this time. In sum, we consider APC Ile1307Lys to be a risk allele. The National Comprehensive Cancer Network has management guidelines for individuals carrying the APC Ile1307Lys risk allele (NCCN).\"}"]}
{"assertion_type":"variation to disease","version":"7","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/10Jq49tz/AD_XL_ClassificationScheme_03.2017_Ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16228836\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28125075\",\"@Source\":\"PubMed\"}}]}}","date_created":"2014-08-01","clinical_assertion_observation_ids":["SCV000183892.0"],"submitter_id":"61756","date_last_updated":"2019-08-03","trait_set_id":"13598","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"Pathogenic","submission_id":"61756.2018-07-30","submission_names":["SUB4348735"],"rcv_accession_id":"RCV000115087","internal_id":"302407","variation_id":"822","clinical_assertion_trait_set_id":"SCV000183892","local_key":"a4793","record_status":"current","interpretation_date_last_evaluated":"2018-02-28","id":"SCV000183892","interpretation_comments":["{\"text\":\"Lines of evidence used in support of classification: Significant disease association in appropriately sized case-control study(ies),Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation,Other strong data supporting pathogenic classification\"}"]}
{"assertion_type":"variation to disease","version":"9","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}}]}}","date_created":"2014-06-03","clinical_assertion_observation_ids":["SCV000153895.0"],"submitter_id":"500031","date_last_updated":"2019-08-15","trait_set_id":"6265","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","interpretation_description":"risk factor","submission_id":"500031.2019-03-28","submission_names":["SUB5371970"],"rcv_accession_id":"RCV000020088","internal_id":"279290","variation_id":"822","clinical_assertion_trait_set_id":"SCV000153895","local_key":"7840|MedGen:C2713442","record_status":"current","interpretation_date_last_evaluated":"2019-01-14","id":"SCV000153895","interpretation_comments":["{\"text\":\"This sequence change replaces isoleucine with lysine at codon 1307 of the APC protein (p.Ile1307Lys). The isoleucine residue is weakly conserved and there is a moderate physicochemical difference between isoleucine and lysine. This variant is present in population databases (rs1801155, ExAC 0.3%). This variant is found in ~10% of Ashkenazi Jewish individuals and ~3% of Sephardic Jewish individuals (PMID: 23896379). Other studies have reported a 6-7% frequency in Ashkenazi individuals (PMID: 9288102). This variant is found in ~28% of Ashkenazi Jewish individuals with familial colorectal cancer (PMID: 9288102). ClinVar contains an entry for this variant (Variation ID: 822). In a large meta-analysis involving ~10,000 cases and controls (PMID: 23576677), Ashkenazi Jewish individuals who carried the I1307K change had a significantly increased risk of colorectal cancer (OR=2.17, 95% CI=1.65-2.86). By contrast, the I1307K change did not appear to confer any additional risk of colorectal cancer in non-Ashkenazi Jewish individuals (OR=1.36, 95% CI=0.59-3.13). This DNA substitution converts an AAATAAAA sequence element into an extended tract of eight adenosine nucleotides (A8). The A8 mononucleotide tract created by this change has been shown to confer an increased propensity for somatic truncating mutations on this allele (PMID: 9751605). In summary, this is a frequently observed variant that is associated with a 2-fold increased risk of colorectal cancer in the Ashkenazi Jewish population. An increased risk of colorectal cancer in individuals who are not of Ashkenazi Jewish ancestry has not been established.\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}],\"StudyDescription\":{\"$\":\"Variants for BRCA1/2 tests\"}}","date_created":"2017-04-13","clinical_assertion_observation_ids":["SCV000540939.0"],"submitter_id":"1006","date_last_updated":"2019-08-03","trait_set_id":"774","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"1006.2017-02-23","submission_names":["BRCA12"],"rcv_accession_id":"RCV000476410","internal_id":"1053858","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000540939","local_key":"NM_007294.3:c.4065_4068delTCAA|Familial cancer of breast","record_status":"current","interpretation_date_last_evaluated":"2017-02-23","id":"SCV000540939","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_(2015)_v1.pdf\"}}}],\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"21559243\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23683081\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24549055\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23633455\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17018160\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21324516\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"7894493\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24556621\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23175448\",\"@Source\":\"PubMed\"}}]}}","date_created":"2015-03-28","clinical_assertion_observation_ids":["SCV000220878.0"],"submitter_id":"320494","date_last_updated":"2019-08-03","trait_set_id":"1917","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Likely pathogenic","submission_id":"320494.2015-03-11","submission_names":["Counsyl_2015_03_01"],"rcv_accession_id":"RCV000019243","internal_id":"397634","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000220878","local_key":"NM_007294.3(BRCA1):c.4065_4068delTCAA","record_status":"current","interpretation_date_last_evaluated":"2014-11-14","id":"SCV000220878","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"LabCorp Variant Classification Summary - May 2015.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"8531967\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20104584\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10699917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21702907\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-03-15","clinical_assertion_observation_ids":["SCV000699105.0"],"submitter_id":"500026","date_last_updated":"2019-08-03","trait_set_id":"7920","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"500026.2018-01-25","submission_names":["2016-2017-variants"],"rcv_accession_id":"RCV000048431","internal_id":"1365457","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000699105","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:C0677776","record_status":"current","interpretation_date_last_evaluated":"2017-08-22","id":"SCV000699105","interpretation_comments":["{\"text\":\"Variant summary: The BRCA1 c.4065_4068delTCAA (p.Asn1355Lysfs) variant results in a premature termination codon, predicted to cause a truncated or absent BRCA1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.4117G\u003eT, p.Glu1373X; c.4158_4162delCTCTC, p.Ser1387fs). This variant has been reported in numerous HBOC patients with positive family history (e.g. Langston 1996, Spitzer 2000, Evans 2004, Borg 2010). This variant is absent in 121322 control chromosomes, suggesting that it is not a common, benign variant. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","date_created":"2018-10-05","clinical_assertion_observation_ids":["SCV000839242.0"],"submitter_id":"500035","date_last_updated":"2019-08-03","trait_set_id":"7920","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"500035.2018-08-20","submission_names":["SUB4427121"],"rcv_accession_id":"RCV000048431","internal_id":"1611812","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000839242","local_key":"NC_000017.10:g.41243480_41243483delTTGA|MedGen:C0677776","record_status":"current","interpretation_date_last_evaluated":"2018-07-02","id":"SCV000839242","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2018-12-20","clinical_assertion_observation_ids":["SCV000863590.0"],"submitter_id":"500086","date_last_updated":"2019-08-03","trait_set_id":"20192","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"500086.2018-07-18","submission_names":["SUB4310295"],"rcv_accession_id":"RCV000735453","internal_id":"1688796","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000863590","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:CN221562","record_status":"current","interpretation_date_last_evaluated":"2010-07-08","id":"SCV000863590","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ENIGMA BRCA1/2 Classification Criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ENIGMA BRCA1/2 Classification Criteria (2015)\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/hxnfuuxx/enigma_rules_2015-03-26.pdf\"}}},\"StudyDescription\":{\"$\":\"ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) is a consortium focused on determining the clinical significance of variants in BRCA1, BRCA2 and other known/suspected breast cancer genes. http://enigmaconsortium.org/\"}}","date_created":"2016-06-24","clinical_assertion_observation_ids":["SCV000282322.0"],"submitter_id":"504863","date_last_updated":"2019-08-03","trait_set_id":"1917","review_status":"reviewed by expert panel","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"504863.2016-06-09","submission_names":["ENIGMA_2015-08-17"],"rcv_accession_id":"RCV000019243","internal_id":"537053","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000282322","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","record_status":"current","interpretation_date_last_evaluated":"2016-04-22","id":"SCV000282322","interpretation_comments":["{\"text\":\"Variant allele predicted to encode a truncated non-functional protein.\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-05-25","clinical_assertion_observation_ids":["SCV000577930.0"],"submitter_id":"505214","date_last_updated":"2019-08-03","trait_set_id":"1917","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"505214.2017-03-15","submission_names":["BRCA_Malaga"],"rcv_accession_id":"RCV000019243","internal_id":"1125848","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000577930","local_key":"GNL0017|OMIM:604370","record_status":"current","interpretation_date_last_evaluated":"2017-01-01","id":"SCV000577930","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-04-21","clinical_assertion_observation_ids":["SCV000564378.0"],"submitter_id":"505260","date_last_updated":"2019-08-31","trait_set_id":"1917","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"505260.2017-04-17","submission_names":[],"rcv_accession_id":"RCV000019243","internal_id":"1099012","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000564378","local_key":"NM_007294.3:c.4065_4068del|MedGen:C2676676","record_status":"current","interpretation_date_last_evaluated":"2015-11-20","id":"SCV000564378","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2016-07-29","clinical_assertion_observation_ids":["SCV000296801.0"],"submitter_id":"505504","date_last_updated":"2019-08-03","trait_set_id":"9590","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"505504.2016-07-19","submission_names":[],"rcv_accession_id":"RCV000238776","internal_id":"574372","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000296801","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:CN169374","record_status":"current","interpretation_date_last_evaluated":"2016-07-01","id":"SCV000296801","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}],\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"12402332\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"12698193\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"9649133\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"3405339\",\"@Source\":\"pmc\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"8571953\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"9150148\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"3893336\",\"@Source\":\"pmc\"}}]}","date_created":"2017-07-26","clinical_assertion_observation_ids":["SCV000584013.0"],"submitter_id":"505785","date_last_updated":"2019-08-03","trait_set_id":"1917","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"505785.2017-07-24","submission_names":["SUB2892902"],"title":"SUB2892902","rcv_accession_id":"RCV000019243","internal_id":"1139118","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000584013","local_key":"SUB2892902","record_status":"current","interpretation_date_last_evaluated":"2017-07-21","id":"SCV000584013","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-02-15","clinical_assertion_observation_ids":["SCV000683147.0"],"submitter_id":"505849","date_last_updated":"2019-08-03","trait_set_id":"13598","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"505849.2017-10-26","submission_names":["SUB3163908"],"rcv_accession_id":"RCV000131887","internal_id":"1338690","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000683147","local_key":"Db4KrQBSZeoE7-orUyypkQ9ffftxzNCEBpQllhdTwYY|MedGen:C0027672","record_status":"current","interpretation_date_last_evaluated":"2015-04-13","id":"SCV000683147","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2017-08-25","clinical_assertion_observation_ids":["SCV000591484.0"],"submitter_id":"506152","date_last_updated":"2019-08-03","trait_set_id":"7920","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"506152.2017-04-19","submission_names":["SHS20170111"],"rcv_accession_id":"RCV000048431","internal_id":"1147928","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000591484","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:C0677776","record_status":"current","id":"SCV000591484","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2017-08-04","clinical_assertion_observation_ids":["SCV000587372.0"],"submitter_id":"506247","date_last_updated":"2019-08-03","trait_set_id":"7920","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"506247.2017-08-04","submission_names":["RMGL-WCRI-05152017"],"rcv_accession_id":"RCV000048431","internal_id":"1140299","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000587372","local_key":"286798|Orphanet:ORPHA145","record_status":"current","interpretation_date_last_evaluated":"2014-01-31","id":"SCV000587372","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"StudyName\":{\"$\":\"VKGL Data-share Consensus\"}}","date_created":"2018-04-06","clinical_assertion_observation_ids":["SCV000733615.0"],"submitter_id":"506382","date_last_updated":"2019-08-03","trait_set_id":"1917","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"506382.2018-04-04","submission_names":["SUB3868021"],"rcv_accession_id":"RCV000019243","internal_id":"1414776","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000733615","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","record_status":"current","id":"SCV000733615","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACGS Guidelines, 2013\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/3yyso7ro/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf\"}}},\"StudyName\":{\"$\":\"VKGL Data-share Consensus\"}}","date_created":"2018-04-18","clinical_assertion_observation_ids":["SCV000744620.0"],"submitter_id":"506497","date_last_updated":"2019-08-03","trait_set_id":"1917","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"506497.2018-04-09","submission_names":["SUB3885264"],"rcv_accession_id":"RCV000019243","internal_id":"1451074","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000744620","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","record_status":"current","interpretation_date_last_evaluated":"2017-05-31","id":"SCV000744620","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"2","date_created":"2014-03-30","clinical_assertion_observation_ids":["SCV000144954.0","SCV000144954.1","SCV000144954.2","SCV000144954.3","SCV000144954.4","SCV000144954.5","SCV000144954.6","SCV000144954.7","SCV000144954.8","SCV000144954.9","SCV000144954.10","SCV000144954.11","SCV000144954.12","SCV000144954.13","SCV000144954.14","SCV000144954.15","SCV000144954.16","SCV000144954.17","SCV000144954.18","SCV000144954.19","SCV000144954.20","SCV000144954.21","SCV000144954.22","SCV000144954.23","SCV000144954.24","SCV000144954.25"],"submitter_id":"504196","date_last_updated":"2019-08-03","trait_set_id":"1917","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"504196.2014-03-28","submission_names":[],"rcv_accession_id":"RCV000019243","internal_id":"261852","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000144954","local_key":"U14680.1:n.4184_4187delTCAA|MedGen:C2676676","record_status":"current","interpretation_date_last_evaluated":"2002-05-29","id":"SCV000144954","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"3","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2015-03-28","clinical_assertion_observation_ids":["SCV000219238.0"],"submitter_id":"1050","date_last_updated":"2019-08-03","trait_set_id":"7920","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"1050.2017-08-28","submission_names":["CHEO20170828_update"],"rcv_accession_id":"RCV000048431","internal_id":"395994","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000219238","local_key":"1776816|Orphanet:ORPHA145","record_status":"current","interpretation_date_last_evaluated":"2017-02-01","id":"SCV000219238","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"3","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest pathogenicity assessment criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"26295337\",\"@Source\":\"PubMed\"}}}","date_created":"2016-07-29","clinical_assertion_observation_ids":["SCV000296305.0"],"submitter_id":"500110","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"500110.2018-08-31","submission_names":["SUB4481696"],"rcv_accession_id":"RCV000159924","internal_id":"573876","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000296305","local_key":"2420169|not provided","record_status":"current","interpretation_date_last_evaluated":"2015-03-02","id":"SCV000296305","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"3","submitted_assembly":"hg18","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"CIMBA Mutation Classification guidelines May 2016\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"CIMBA_Mutation_Classification_guidelines_May16.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/MIHuUwlX/CIMBA_Mutation_Classification_guidelines_May16.pdf\"}}}}","date_created":"2016-11-04","clinical_assertion_observation_ids":["SCV000325829.0"],"submitter_id":"505954","date_last_updated":"2019-08-03","trait_set_id":"1917","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"505954.2016-10-28","submission_names":["CIMBA_20161005"],"rcv_accession_id":"RCV000019243","internal_id":"624937","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000325829","local_key":"NM_007294.3:c.4065_4068del|OMIM:604370","record_status":"current","interpretation_date_last_evaluated":"2015-10-02","id":"SCV000325829","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"4","date_created":"2011-01-25","clinical_assertion_observation_ids":["SCV000039531.0"],"submitter_id":"3","date_last_updated":"2019-08-03","trait_set_id":"1917","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"3.2010-12-30","submission_names":[],"title":"BRCA1, 4-BP DEL, 4185TCAA_BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1","rcv_accession_id":"RCV000019243","internal_id":"39531","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000039531","local_key":"113705.0015_BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1","record_status":"current","interpretation_date_last_evaluated":"1994-12-01","id":"SCV000039531","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"5","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/10Jq49tz/AD_XL_ClassificationScheme_03.2017_Ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"7837387\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"8531967\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10699917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16455195\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17100994\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24504028\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24556621\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27553291\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28831036\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28724667\",\"@Source\":\"PubMed\"}}]}}","date_created":"2014-08-01","clinical_assertion_observation_ids":["SCV000186942.0"],"submitter_id":"61756","date_last_updated":"2019-08-03","trait_set_id":"13598","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"61756.2018-07-30","submission_names":["SUB4348735"],"rcv_accession_id":"RCV000131887","internal_id":"305457","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000186942","local_key":"a89762","record_status":"current","interpretation_date_last_evaluated":"2018-03-15","id":"SCV000186942","interpretation_comments":["{\"text\":\"Lines of evidence used in support of classification: Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)\"}"]}
{"assertion_type":"variation to disease","version":"6","date_created":"2012-11-07","clinical_assertion_observation_ids":["SCV000053742.0"],"submitter_id":"500037","date_last_updated":"2019-08-03","trait_set_id":"1917","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"500037.2015-12-29","submission_names":[],"title":"NM_007294.3:c.4065_4068delTCAA AND Breast-ovarian cancer, familial 1","rcv_accession_id":"RCV000019243","internal_id":"89357","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000053742","local_key":"SCRP_var_186","record_status":"current","interpretation_date_last_evaluated":"2013-03-21","id":"SCV000053742","interpretation_comments":[]}
{"assertion_type":"variation to disease","version":"11","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21559243\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"8571953\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}}]}}","date_created":"2013-07-02","clinical_assertion_observation_ids":["SCV000076444.0"],"submitter_id":"500031","date_last_updated":"2019-08-15","trait_set_id":"7920","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"500031.2019-03-28","submission_names":["SUB5371970"],"rcv_accession_id":"RCV000048431","internal_id":"124374","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000076444","local_key":"306942|MedGen:C0677776","record_status":"current","interpretation_date_last_evaluated":"2019-01-09","id":"SCV000076444","interpretation_comments":["{\"text\":\"This sequence change creates a premature translational stop signal (p.Asn1355Lysfs*10) in the BRCA1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs80357508, ExAC 0.006%). This variant has been reported in multiple individuals and families affected with breast and ovarian cancer (PMID: 14757871, 8571953, 11802209, 21559243). This variant is also known as 4184del4 in the literature. ClinVar contains an entry for this variant (Variation ID: 17674). Loss-of-function variants in BRCA1 are known to be pathogenic (PMID: 20104584). For these reasons, this variant has been classified as Pathogenic.\"}"]}
{"assertion_type":"variation to disease","version":"13","submitted_assembly":"GRCh37","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2015-02-19","clinical_assertion_observation_ids":["SCV000210049.0"],"submitter_id":"26957","date_last_updated":"2019-08-03","trait_set_id":"9460","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","interpretation_description":"Pathogenic","submission_id":"26957.2019-01-29","submission_names":["SUB5098196"],"rcv_accession_id":"RCV000159924","internal_id":"375724","variation_id":"17674","clinical_assertion_trait_set_id":"SCV000210049","local_key":"GDX:7571|Not Provided","record_status":"current","interpretation_date_last_evaluated":"2018-12-19","id":"SCV000210049","interpretation_comments":["{\"text\":\"This deletion of four nucleotides in BRCA1 is denoted c.4065_4068delTCAA at the cDNA level and p.Asn1355LysfsX10 (N1355KfsX10) at the protein level. The normal sequence, with the bases that are deleted in brackets, is ATAA[delTCAA]GAAG. The deletion causes a frameshift, which changes an Asparagine to a Lysine at codon 1355, and creates a premature stop codon at position 10 of the new reading frame. This variant is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. This variant, also reported as BRCA1 4184del4 or 4184_4187delTCAA using alternate nomenclature, has been reported in association with hereditary breast cancer and in multiple individuals with breast, ovarian, or prostate cancer (Friedman 1994, Neuhausen 1996, Liede 2002, Meindl 2002, Farooq 2011, Couch 2015, Bu 2016, Chan 2018). We consider this variant to be pathogenic.\"}"]}
{"assertion_type":"variation to disease","version":"2","submitted_assembly":"GRCh37","content":"{\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27884168\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-01-26","clinical_assertion_observation_ids":["SCV000494066.0"],"submitter_id":"505789","date_last_updated":"2019-08-03","trait_set_id":"770","review_status":"no assertion criteria provided","variation_archive_id":"VCV000424841","interpretation_description":"Uncertain significance","submission_id":"505789.2016-12-30","submission_names":["Ataxia_Telangiectasia"],"rcv_accession_id":"RCV000416302","internal_id":"966237","variation_id":"424841","clinical_assertion_trait_set_id":"SCV000494066","local_key":"NM_000051.3:c.[497-1G\u003eA];[1236-2A\u003eT]|OMIM:208900","record_status":"current","id":"SCV000494066","interpretation_comments":["{\"text\":\"In this patient identified as compound heterozygous variants NM_000051.3:c.[497-1G\u003eA];[1236-2A\u003eT].\"}"]}
{"assertion_type":"variation to disease","version":"1","submitted_assembly":"not applicable","content":"{\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"21655256\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"http://www.arup.utah.edu/database/MEN2/MEN2_display.php\"}}]}}","date_created":"2018-07-27","clinical_assertion_observation_ids":["SCV000788260.0"],"submitter_id":"506018","date_last_updated":"2019-08-03","trait_set_id":"8702","review_status":"no assertion criteria provided","variation_archive_id":"VCV000549768","interpretation_description":"Pathogenic","submission_id":"506018.2018-05-10","submission_names":["MEN2 update May 2018"],"rcv_accession_id":"RCV000664336","internal_id":"1538355","variation_id":"549768","clinical_assertion_trait_set_id":"SCV000788260","local_key":"6|MedGen:CN073359","record_status":"current","interpretation_date_last_evaluated":"2018-05-04","id":"SCV000788260","interpretation_comments":["{\"text\":\"The p.V292M/R67H/R982C allele was found in trans with p.C634Y in a Chinese family, genotype c.[1901G\u003eA];[200G\u003eA;874G\u003eA;2944C\u003eT]. One family member had both variant RET alleles and MTC onset at 13 yrs. Family members with only the p.C634Y mutation had MEN2A. Family members with the p.V292M/R67H/R982C allele had MTC (70 yr) and C-cell hyperplasia (44 yr). Variants p.R67H and p.R982C are common and likely benign, GnomAD frequency 0.1% and 2%, respectively (gnomad.broadinstitute.org/gene/ENSG00000165731). For reports of p.V292M alone, see c.874G\u003eA.\"}"]}
